Aurobindo Pharma reports 34% fall in Q4 net profit

30 May 2012 Evaluate

Aurobindo Pharma has reported results for the quarter and year ended March 31, 2012.

The company’s net profit for the fourth quarter ended March 31, 2012 fell 33.70% to Rs 87.91 crore as compared to Rs 132.59 crore for the quarter ended March 31, 2011. However, the total income has increased by 3.51% to Rs 1100.41 crore for the quarter under review from Rs 1063.10 crore for the corresponding quarter of the previous year.

For the year ended March 31, 2012, the company reported a net loss of Rs 42.61 crore as compared to net profit of Rs 593.80 crore for the previous year. However, the company’s total income has increased by 3.74% to Rs 4300.51 crore for the year from Rs 4145.63 crore in the previous year.

On consolidated basis, the Group’s net loss after taxes and minority interest stood at Rs 123.51 crore for the year under review as compared to net profit of Rs 563.45 crore for the period ago. However, its total income has increased by 5.60% to Rs 4652.10 crore for the year ended March 31, 2012 from Rs 4405.36 crore in the previous year.

Aurobindo Pharma Share Price

1211.70 -14.45 (-1.18%)
04-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1704.00
Dr. Reddys Lab 1240.15
Cipla 1325.55
Zydus Lifesciences 905.05
Lupin 2194.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×